Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 10
Submit an article Journal homepage
486
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

ERK-dependent IL-6 positive feedback loop mediates resistance against a combined treatment using danusertib and BKM120 in Burkitt lymphoma cell lines

Jun LiuCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; View further author information
,
Junshik HongCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; ;Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; ;Biomedical Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; View further author information
,
Kwang-Sung AhnPDXen Biosystems Co, Daejeon, Republic of KoreaView further author information
,
Junhyeok GoPDXen Biosystems Co, Daejeon, Republic of KoreaView further author information
,
Heejoo HanCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; View further author information
,
Jihyun ParkCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; View further author information
,
Dongchan KimCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; View further author information
,
Hyejoo ParkCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; View further author information
,
Youngil KohCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; ;Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; ;Biomedical Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; View further author information
,
Dong-Yeop ShinCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; ;Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; ;Biomedical Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; View further author information
&
Sung-Soo YoonCancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; ;Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea; ;Biomedical Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea; Correspondence[email protected]
View further author information
 show all
Pages 2532-2540 | Received 16 Nov 2018, Accepted 06 Mar 2019, Published online: 05 Apr 2019

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xue-Li Jing & Shi-Wu Chen. (2021) Aurora kinase inhibitors: a patent review (2014-2020). Expert Opinion on Therapeutic Patents 31:7, pages 625-643.
Read now

Articles from other publishers (6)

Jun Liu, Suji Min, Dongchan Kim, Jihyun Park, Eunchae Park, Youngil Koh, Dong-Yeop Shin, Tae Kon Kim, Ja Min Byun, Sung-Soo Yoon & Junshik Hong. (2023) Epigenetic priming improves salvage chemotherapy in diffuse large B-cell lymphoma via endogenous retrovirus-induced cGAS-STING activation. Clinical Epigenetics 15:1.
Crossref
Yuyan Wang, Ni Zheng, Tingting Sun, Hui Zhao, Ying Chen & Congcong Liu. (2022) Role of TGM2 in T‑cell lymphoblastic lymphoma via regulation of IL‑6/JAK/STAT3 signalling. Molecular Medicine Reports 25:3.
Crossref
IsmailAyberk Kirbiyik & AhmetAta Ozcimen. (2021) The effect of danusertib, an Aurora kinase inhibitor, onto the cytotoxicity, cell cycle and apoptosis in pancreatic ductal adenocarcinoma cells. Journal of Cancer Research and Therapeutics 17:6, pages 1419.
Crossref
Jun Liu, Junshik Hong, Heejoo Han, Jihyun Park, Dongchan Kim, Hyejoo Park, Myunggon Ko, Youngil Koh, Dong-Yeop Shin & Sung-Soo Yoon. (2020) Decreased vitamin C uptake mediated by SLC2A3 promotes leukaemia progression and impedes TET2 restoration. British Journal of Cancer 122:10, pages 1445-1452.
Crossref
Mahamat Babagana, Julia V. Kichina, Hannah Slabodkin, Sydney Johnson, Alexei Maslov, Lorin Brown, Kristopher Attwood, Mikhail A. Nikiforov & Eugene S. Kandel. (2019) The role of polo‐like kinase 3 in the response of BRAF‐mutant cells to targeted anticancer therapies. Molecular Carcinogenesis 59:1, pages 5-14.
Crossref
Joo Hyun Kim, Won Seog Kim & Chaehwa Park. (2019) Interleukin-6 mediates resistance to PI3K-pathway–targeted therapy in lymphoma. BMC Cancer 19:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.